Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shreastha Gautam

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Therapeutic Delivery|October 14, 2025
Development and evaluation of targeted liposomes for improved doxorubicin and quercetin delivery for MDR breast cancerShreastha Gautam, Rashmi Maurya, Preeti Patel, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 29, 2025
Comprehensive advances in HER2-positive and HER2-negative breast cancer: unveiling molecular mechanisms and exploring cutting-edge targeted therapies for enhanced patient outcomesNayan Sood, Rashmi Maurya, Shreastha Gautam, et al.
Assay and Drug Development Technologies|February 26, 2025
Mini Review on the Lyophilization: A Basic Requirement for Formulation Development and Stability ModifierSachin Joshi, Priya Jindal, Shreastha Gautam, et al.
Current Pharmaceutical Design|July 15, 2025
Recent Developments in Vesicular Nanocarriers for Targeted Drug Delivery in Breast CancerShreastha Gautam, Priya Jindal, Sachin Joshi, et al.
International Journal of Pharmaceutics|April 5, 2025
Recent doxorubicin-conjugates in cancer drug delivery: Exploring conjugation strategies for enhanced efficacy and reduced toxicityShreastha Gautam, Sachin Joshi, Priya Jindal, et al.
Current Drug Targets|May 10, 2024
Comprehensive Analysis of Omicron Subvariants: EG.5 Rise, Vaccination Strategies, and Global ImpactDebayan Sil, Shreastha Gautam, Shubhi Saxena, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapeutic Delivery|October 14, 2025
Development and evaluation of targeted liposomes for improved doxorubicin and quercetin delivery for MDR breast cancerShreastha Gautam, Rashmi Maurya, Preeti Patel, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 29, 2025
Comprehensive advances in HER2-positive and HER2-negative breast cancer: unveiling molecular mechanisms and exploring cutting-edge targeted therapies for enhanced patient outcomesNayan Sood, Rashmi Maurya, Shreastha Gautam, et al.
Assay and Drug Development Technologies|February 26, 2025
Mini Review on the Lyophilization: A Basic Requirement for Formulation Development and Stability ModifierSachin Joshi, Priya Jindal, Shreastha Gautam, et al.
Current Pharmaceutical Design|July 15, 2025
Recent Developments in Vesicular Nanocarriers for Targeted Drug Delivery in Breast CancerShreastha Gautam, Priya Jindal, Sachin Joshi, et al.
International Journal of Pharmaceutics|April 5, 2025
Recent doxorubicin-conjugates in cancer drug delivery: Exploring conjugation strategies for enhanced efficacy and reduced toxicityShreastha Gautam, Sachin Joshi, Priya Jindal, et al.
Current Drug Targets|May 10, 2024
Comprehensive Analysis of Omicron Subvariants: EG.5 Rise, Vaccination Strategies, and Global ImpactDebayan Sil, Shreastha Gautam, Shubhi Saxena, et al.
Pageof 1